Cargando…

Xenofree generation of limbal stem cells for ocular surface advanced cell therapy

BACKGROUND: Limbal stem cells (LSC) sustain the corneal integrity and homeostasis. LSC deficiency (LSCD) leads to loss of corneal transparency and blindness. A clinical approach to treat unilateral LSCD comprises autologous cultured limbal epithelial stem cell transplantation (CLET). CLET uses xenob...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieto-Nicolau, Nuria, Martínez-Conesa, Eva M., Velasco-García, Alba M., Aloy-Reverté, Caterina, Vilarrodona, Anna, Casaroli-Marano, Ricardo P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894225/
https://www.ncbi.nlm.nih.gov/pubmed/31801638
http://dx.doi.org/10.1186/s13287-019-1501-9
_version_ 1783476346522959872
author Nieto-Nicolau, Nuria
Martínez-Conesa, Eva M.
Velasco-García, Alba M.
Aloy-Reverté, Caterina
Vilarrodona, Anna
Casaroli-Marano, Ricardo P.
author_facet Nieto-Nicolau, Nuria
Martínez-Conesa, Eva M.
Velasco-García, Alba M.
Aloy-Reverté, Caterina
Vilarrodona, Anna
Casaroli-Marano, Ricardo P.
author_sort Nieto-Nicolau, Nuria
collection PubMed
description BACKGROUND: Limbal stem cells (LSC) sustain the corneal integrity and homeostasis. LSC deficiency (LSCD) leads to loss of corneal transparency and blindness. A clinical approach to treat unilateral LSCD comprises autologous cultured limbal epithelial stem cell transplantation (CLET). CLET uses xenobiotic culture systems with potential zoonotic transmission risks, and regulatory guidelines make necessary to find xenofree alternatives. METHODS: We compared two xenofree clinical grade media and two feeder layers. We used CnT07, a defined commercial medium for keratinocytes, and a modified xenofree supplemented hormonal epithelial medium with human serum (XSHEM). Optimal formulation was used to compare two feeder layers: the gold standard 3T3 murine fibroblasts and human processed lipoaspirate cells (PLA). We tested the expressions of ΔNp63α and cytokeratin 3 and 12 by qPCR and immunofluorescence. Morphology, viability, clonogenicity, proliferation, and cell growth assays were carried out. We also evaluated interleukin 6 (IL-6) and stromal-derived factor 1 (SDF-1) by qPCR and ELISA. RESULTS: XSHEM maintained better LSC culture viability and morphology than CnT07. Irradiated PLA feeder cells improved the undifferentiated state of LSC and enhanced their growth and clonogenicity stimulating IL-6 secretion and SDF-1 expression, as well as increased proliferation and cell growth when compared with irradiated 3T3 feeder cells. CONCLUSIONS: The combination of XSHEM and PLA feeder cells efficiently sustained LSC xenofree cultures for clinical application. Moreover, PLA feeder layers were able to improve the LSC potential characteristics. Our results would have direct clinical application in CLET for advanced therapy. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-6894225
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68942252019-12-11 Xenofree generation of limbal stem cells for ocular surface advanced cell therapy Nieto-Nicolau, Nuria Martínez-Conesa, Eva M. Velasco-García, Alba M. Aloy-Reverté, Caterina Vilarrodona, Anna Casaroli-Marano, Ricardo P. Stem Cell Res Ther Research BACKGROUND: Limbal stem cells (LSC) sustain the corneal integrity and homeostasis. LSC deficiency (LSCD) leads to loss of corneal transparency and blindness. A clinical approach to treat unilateral LSCD comprises autologous cultured limbal epithelial stem cell transplantation (CLET). CLET uses xenobiotic culture systems with potential zoonotic transmission risks, and regulatory guidelines make necessary to find xenofree alternatives. METHODS: We compared two xenofree clinical grade media and two feeder layers. We used CnT07, a defined commercial medium for keratinocytes, and a modified xenofree supplemented hormonal epithelial medium with human serum (XSHEM). Optimal formulation was used to compare two feeder layers: the gold standard 3T3 murine fibroblasts and human processed lipoaspirate cells (PLA). We tested the expressions of ΔNp63α and cytokeratin 3 and 12 by qPCR and immunofluorescence. Morphology, viability, clonogenicity, proliferation, and cell growth assays were carried out. We also evaluated interleukin 6 (IL-6) and stromal-derived factor 1 (SDF-1) by qPCR and ELISA. RESULTS: XSHEM maintained better LSC culture viability and morphology than CnT07. Irradiated PLA feeder cells improved the undifferentiated state of LSC and enhanced their growth and clonogenicity stimulating IL-6 secretion and SDF-1 expression, as well as increased proliferation and cell growth when compared with irradiated 3T3 feeder cells. CONCLUSIONS: The combination of XSHEM and PLA feeder cells efficiently sustained LSC xenofree cultures for clinical application. Moreover, PLA feeder layers were able to improve the LSC potential characteristics. Our results would have direct clinical application in CLET for advanced therapy. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2019-12-04 /pmc/articles/PMC6894225/ /pubmed/31801638 http://dx.doi.org/10.1186/s13287-019-1501-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Nieto-Nicolau, Nuria
Martínez-Conesa, Eva M.
Velasco-García, Alba M.
Aloy-Reverté, Caterina
Vilarrodona, Anna
Casaroli-Marano, Ricardo P.
Xenofree generation of limbal stem cells for ocular surface advanced cell therapy
title Xenofree generation of limbal stem cells for ocular surface advanced cell therapy
title_full Xenofree generation of limbal stem cells for ocular surface advanced cell therapy
title_fullStr Xenofree generation of limbal stem cells for ocular surface advanced cell therapy
title_full_unstemmed Xenofree generation of limbal stem cells for ocular surface advanced cell therapy
title_short Xenofree generation of limbal stem cells for ocular surface advanced cell therapy
title_sort xenofree generation of limbal stem cells for ocular surface advanced cell therapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894225/
https://www.ncbi.nlm.nih.gov/pubmed/31801638
http://dx.doi.org/10.1186/s13287-019-1501-9
work_keys_str_mv AT nietonicolaunuria xenofreegenerationoflimbalstemcellsforocularsurfaceadvancedcelltherapy
AT martinezconesaevam xenofreegenerationoflimbalstemcellsforocularsurfaceadvancedcelltherapy
AT velascogarciaalbam xenofreegenerationoflimbalstemcellsforocularsurfaceadvancedcelltherapy
AT aloyrevertecaterina xenofreegenerationoflimbalstemcellsforocularsurfaceadvancedcelltherapy
AT vilarrodonaanna xenofreegenerationoflimbalstemcellsforocularsurfaceadvancedcelltherapy
AT casarolimaranoricardop xenofreegenerationoflimbalstemcellsforocularsurfaceadvancedcelltherapy